These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12151128)

  • 1. Evaluation and prediction of effects of antiepileptic drugs in a variety of other CNS disorders.
    Lopes da Silva F; Post RM
    Epilepsy Res; 2002 Jun; 50(1-2):191-3. PubMed ID: 12151128
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders.
    Dalkara S; Karakurt A
    Curr Top Med Chem; 2012; 12(9):1033-71. PubMed ID: 22352861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary prevention of epilepsy in patients with different epileptogenic conditions.
    Beghi E; Beghi M; Cornaggia C
    Expert Rev Neurother; 2004 Nov; 4(6):945-52. PubMed ID: 15853521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa opioids: therapeutic considerations in epilepsy and CNS injury.
    Tortella FC; DeCoster MA
    Clin Neuropharmacol; 1994 Oct; 17(5):403-16. PubMed ID: 9316689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (R)- and (S)-4-Amino-3-(trimethylsilyl)methylbutanoic acids ameliorate neuropathic pain without central nervous system-related side effects.
    Muratake H; Ito A; Toda T; Suzuki H; Fukasawa H; Tsuda M; Inoue K; Sugiyama K; Shudo K
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7602-4. PubMed ID: 23103098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diseases of the central nervous system. Pharmacological basis of treatment.
    Gilbert JC
    Br Med J; 1975 Oct; 4(5987):33-5. PubMed ID: 240482
    [No Abstract]   [Full Text] [Related]  

  • 7. Glutamatergic neurotransmission as molecular target of new anticonvulsants.
    Gitto R; De Luca L; De Grazia S; Chimirri A
    Curr Top Med Chem; 2012; 12(9):971-93. PubMed ID: 22352860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
    Gray NA; Zhou R; Du J; Moore GJ; Manji HK
    J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium channels and therapy of central nervous system diseases.
    Taylor CP; Narasimhan LS
    Adv Pharmacol; 1997; 39():47-98. PubMed ID: 9160113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood neurocysticercosis: issues in diagnosis and management.
    Garg RK
    Indian Pediatr; 1995 Sep; 32(9):1023-9. PubMed ID: 8935272
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress and promise of antisense oligonucleotide therapeutics for central nervous system diseases.
    Bishop KM
    Neuropharmacology; 2017 Jul; 120():56-62. PubMed ID: 27998711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools in the Design of Therapeutic Drugs for CNS Disorders: An up-to-date Review.
    Sahu JK; Mishra AK
    Curr Mol Pharmacol; 2018; 11(4):270-278. PubMed ID: 30129422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational CNS medicines research.
    Palmer AM; Alavijeh MS
    Drug Discov Today; 2012 Oct; 17(19-20):1068-78. PubMed ID: 22580061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical approach to patients with neuropathic pain.
    Stillman M
    Cleve Clin J Med; 2006 Aug; 73(8):726-8, 729-30, 733-6 passim. PubMed ID: 16913197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticonvulsants in central pain.
    Finnerup NB; Gottrup H; Jensen TS
    Expert Opin Pharmacother; 2002 Oct; 3(10):1411-20. PubMed ID: 12387687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient control of transient wave forms to prevent spreading depolarizations.
    Dahlem MA; Schneider FM; Schöll E
    J Theor Biol; 2008 Mar; 251(2):202-9. PubMed ID: 18177900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary study on the efficacy and tolerability of newer anticonvulsants in a population of epileptic patients.
    Guevara J; Carmona G; Ortega MP; Iglesias AA
    Med Princ Pract; 2005; 14(1):31-4. PubMed ID: 15608478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive Neuroparacoccidioidomycosis Lesions with Mild Neurological Manifestations.
    Freitas APPO; Moll Souza RS; Falqueto A; Mendes Peçanha P
    Am J Trop Med Hyg; 2021 Sep; 105(5):1127-1128. PubMed ID: 34583339
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbohydrate-based drugs in the treatment of epilepsy, depression and other affective disorders.
    Talisman IJ; Marzabadi CH
    Curr Top Med Chem; 2008; 8(2):159-70. PubMed ID: 18289085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Society for Neuroscience--38th Annual Meeting--Data for therapeutics for CNS diseases and disorders.
    Macauley D; Al-Shamahi A
    IDrugs; 2009 Jan; 12(1):17-9. PubMed ID: 19127499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.